FDA Import Refusal SCS-1442909-8/11/1 — Tianjin Kingyork Pharmaceuticals Co., Ltd

Tianjin Kingyork Pharmaceuticals Co., Ltd — FEI 3013844768

The FDA refused shipment SCS-1442909-8/11/1 from Tianjin Kingyork Pharmaceuticals Co., Ltd (China) on October 9, 2020. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 3 other import refusals on record.

Refusal Details

Date
October 9, 2020
Country
China
Product Category
Drugs and Biologics
Product Code
66VDY99 MISCELLANEOUS PATENT MEDICINES, ETC.
Charges
75